Extract notice to the Minister


Common name / Subject : vedolizumab (CU)
Name of the manufacturer : Takeda
Form : Pd. Perf. I.V.
Dosage : 300 mg

Indication : Colite ulcéreuse

INESSS' Recommendation

Minister's decisions
Inscrire aux listes des médicaments – Médicament d’exception

Evaluation published on April 21, 2017

Download Advice to minister about Entyvio

Extrait de l'Avis au ministre sur Entyvio 104 KiO

Subscribe to our newsletter now